These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 129792)

  • 41. [On changes in the composition of cerebrospinal fluid in the choreatic syndrome].
    Bruck J; Gerstenbrand F; Gnad H; Gründig E; Prosenz P
    J Neurol Sci; 1967; 5(2):257-65. PubMed ID: 4228547
    [No Abstract]   [Full Text] [Related]  

  • 42. Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.
    Constantinescu R; Romer M; Zetterberg H; Rosengren L; Kieburtz K
    Parkinsonism Relat Disord; 2011 Nov; 17(9):714-5. PubMed ID: 21733739
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)].
    Schubotz R; Hausmann L; Kaffarnik H; Zehner J; Oepen H
    Res Exp Med (Berl); 1976 Jul; 167(3):203-15. PubMed ID: 136033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid homovanillic acid in Huntington's chorea.
    Klawans HL
    J Neurol Sci; 1971 Jul; 13(3):277-9. PubMed ID: 4256172
    [No Abstract]   [Full Text] [Related]  

  • 45. [Huntington's chorea--new development in biochemical theories].
    Kanazawa I
    Nihon Rinsho; 1978 May; Suppl():1708-9. PubMed ID: 151157
    [No Abstract]   [Full Text] [Related]  

  • 46. Cerebrospinal fluid choline in extrapyramidal disorders.
    Aquilonius SM; Nyström B; Schuberth J; Sundwall A
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease.
    Gårseth M; Sonnewald U; White LR; Rød M; Zwart JA; Nygaard O; Aasly J
    J Neurosci Res; 2000 Jun; 60(6):779-82. PubMed ID: 10861790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 49. Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
    Yates CM; Magill BE; Davidson D; Murray LG; Wilson H; Pullar IA
    Clin Chim Acta; 1973 Feb; 44(1):139-45. PubMed ID: 4267642
    [No Abstract]   [Full Text] [Related]  

  • 50. Magnesium metabolism in Huntington's chorea.
    Jones JE; Desper PC; Fink EB
    Metabolism; 1965 Jul; 14(7):813-8. PubMed ID: 25286470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between CT scan changes and the duration of illness in Huntington's chorea (author's transl)].
    Konagaya M; Mukai E; Murakami N; Muroga T; Sobue I
    Rinsho Shinkeigaku; 1980 Feb; 20(2):113-20. PubMed ID: 6445252
    [No Abstract]   [Full Text] [Related]  

  • 52. Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.
    Welch MJ; Markham CH; Jenden DJ
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):367-74. PubMed ID: 132512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].
    Simanyi M; Gerstenbrand F; Gründig E; Schedl R; Weiss H
    Z Neurol; 1973 Mar; 204(1):67-80. PubMed ID: 4121504
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: G.A.B.A. in Huntington's chorea.
    Perry TL; Hansen S; Urquhart N
    Lancet; 1974 May; 1(7864):995-6. PubMed ID: 4133688
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tryptophan loading test in Huntington's chorea].
    Oepen I; Oepen H
    Humangenetik; 1969; 7(3):197-202. PubMed ID: 4240656
    [No Abstract]   [Full Text] [Related]  

  • 56. Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.
    Cramer H; Kohler J; Oepen G; Schomburg G; Schröter E
    J Neurol; 1981; 225(3):183-7. PubMed ID: 6167683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients.
    Kim JS; Kornhuber HH; Holzmüller B; Schmid-Burgk W; Mergner T; Krzepinski G
    Arch Psychiatr Nervenkr (1970); 1980; 228(1):7-10. PubMed ID: 6104477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
    Glaeser BS; Vogel WH; Oleweiler DB; Hare TA
    Biochem Med; 1975 Apr; 12(4):380-5. PubMed ID: 126061
    [No Abstract]   [Full Text] [Related]  

  • 59. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
    Consolo S; Ladinsky H; Bianchi S; Caraceni T
    Arch Psychiatr Nervenkr (1970); 1977 May; 223(3):265-70. PubMed ID: 142461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum levels of phenylalanine and tyrosine in Huntington's chorea.
    Ottosson JO; Rapp W
    Acta Psychiatr Scand Suppl; 1971; 221():89-1. PubMed ID: 4255685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.